Edgar T. Overton

11.9k total citations
194 papers, 5.6k citations indexed

About

Edgar T. Overton is a scholar working on Emergency Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Edgar T. Overton has authored 194 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Emergency Medicine, 88 papers in Infectious Diseases and 52 papers in Epidemiology. Recurrent topics in Edgar T. Overton's work include HIV-related health complications and treatments (96 papers), HIV/AIDS Research and Interventions (60 papers) and HIV Research and Treatment (43 papers). Edgar T. Overton is often cited by papers focused on HIV-related health complications and treatments (96 papers), HIV/AIDS Research and Interventions (60 papers) and HIV Research and Treatment (43 papers). Edgar T. Overton collaborates with scholars based in United States, Ireland and Belgium. Edgar T. Overton's co-authors include Nur F. Önen, Enbal Shacham, Amanda L. Willig, Pablo Tebas, Kristin Mondy, William G. Powderly, Warren Seyfried, Diana Nurutdinova, John T. Brooks and Timothy J. Bush and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Edgar T. Overton

190 papers receiving 5.5k citations

Peers

Countries citing papers authored by Edgar T. Overton

Since Specialization

Citations

This map shows the geographic impact of Edgar T. Overton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar T. Overton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar T. Overton more than expected).

Fields of papers citing papers by Edgar T. Overton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar T. Overton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar T. Overton. The network helps show where Edgar T. Overton may publish in the future.

Co-authorship network of co-authors of Edgar T. Overton

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar T. Overton. A scholar is included among the top collaborators of Edgar T. Overton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar T. Overton. Edgar T. Overton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function 2024 ·Clinical Infectious Diseases ·Kristine M. Erlandson, Triin Umbleja, Heather J. Ribaudo, Jennifer A. Schrack, Edgar T. Overton, Carl J. Fichtenbaum, Kathleen V. Fitch, (unknown), Marissa R Diggs, Kenneth W. Wood, Markella V. Zanni, Gerald S. Bloomfield, Carlos Malvestutto, Judith A. Aberg, Maria C. Rodriguez‐Barradas, (unknown), (unknown), Pamela S. Douglas, Steven Grinspoon, Todd T. Brown	1
2	A COVID-19 monitoring process for healthcare workers utilizing occupational health 2023 ·Occupational Medicine ·James Crosby, (unknown), Gerald McGwin, Sonya L. Heath, Greer Burkholder, (unknown), Edgar T. Overton, (unknown), (unknown), Ricardo Franco, Sarah Nafziger	1
3	Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes 2023 ·AIDS Research and Human Retroviruses ·Mary Clare Masters, (unknown), Jingyan Yang, Edgar T. Overton, Scott Letendre, Susan L. Koletar, Leah H. Rubin, Todd T. Brown, Katherine Tassiopoulos, Kristine M. Erlandson, Frank J. Palella	2
4	Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy 2022 ·The Journal of Infectious Diseases ·Márton Kolossváry, Christopher R. deFilippi, Michael T. Lu, Markella V. Zanni, Evelynne S. Fulda, Borek Foldyna, Heather J. Ribaudo, Thomas Mayrhofer, Ann C. Collier, Gerald S. Bloomfield, Carl J. Fichtenbaum, Edgar T. Overton, Judith A. Aberg, Judith S. Currier, Kathleen V. Fitch, Pamela S. Douglas, Steven Grinspoon	9
5	Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era 2022 ·AIDS ·(unknown), Andrew O. Westfall, Dustin M. Long, Andrea Cherrington, Greer Burkholder, Nicholas Funderburg, James L. Raper, Edgar T. Overton, Amanda L. Willig	19
6	Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIV 2022 ·AIDS Research and Human Retroviruses ·Mohammed Siddiqui, Tony Moore, Dustin M. Long, Greer Burkholder, Amanda L. Willig, Christina Wyatt, Sonya L. Heath, Paul Muntner, Edgar T. Overton	4
7	Bacterial Sexually Transmitted Infection Incidence Among Southern Men Who Have Sex With Men With Human Immunodeficiency Virus in the Treatment as Prevention Era, 2014–2019 2022 ·Clinical Infectious Diseases ·(unknown), John D. Cleveland, Edgar T. Overton, Jeanne Marrazzo	2
8	Recurrent COVID-19 in Hemodialysis: A Case Report of 2 Possible Reinfections 2021 ·Kidney Medicine ·Vinay Krishna, Masood Ahmad, Edgar T. Overton, Gaurav Jain	3
9	A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy 2021 ·Open Forum Infectious Diseases ·Rachel M. Presti, (unknown), Brett Williams, Alan Landay, Jeffrey M. Jacobson, Cara C. Wilson, Carl J. Fichtenbaum, Netanya S. Utay, Michael P. Dubé, Karin L. Klingman, Jacob D. Estes, Jacob K. Flynn, Amanda H. Loftin, Jason M. Brenchley, Adriana Andrade, Douglas Kitch, Edgar T. Overton	12
10	Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus 2021 ·Open Forum Infectious Diseases ·(unknown), Janet Lo, Carlos Malvestutto, Kathleen V. Fitch, Markella V. Zanni, Carl J. Fichtenbaum, Edgar T. Overton, Nwora Lance Okeke, Princy Kumar, Esaú João, Judith A. Aberg, Estebán Martínez, Judith S. Currier, Pamela S. Douglas, Heather J. Ribaudo, Steven Grinspoon	27
11	Sexually transmitted infections and sexual behaviors of men who have sex with men in an American Deep South PrEP clinic 2020 ·International Journal of STD & AIDS ·(unknown), Andrew O. Westfall, Edgar T. Overton, (unknown), Christina A. Muzny, Ellen Eaton	8
12	Genome-wide admixture and association study of subclinical atherosclerosis in the Women’s Interagency HIV Study (WIHS) 2017 ·PLoS ONE ·Aditi Shendre, Howard W. Wiener, Marguerite R. Irvin, Bradley E. Aouizerat, Edgar T. Overton, Jason Lazar, Chenglong Liu, Howard N. Hodis, Nita A. Limdi, Kathleen M. Weber, Stephen J. Gange, Degui Zhi, Michelle Floris-Moore, Ighovwerha Ofotokun, Qibin Qi, David B. Hanna, Robert C. Kaplan, Sadeep Shrestha	10
13	Direct-acting Antivirals in Kidney Transplant Patients: Successful Hepatitis C Treatment and Short Term Reduction in Urinary Protein/Creatinine Ratios 2017 ·SHILAP Revista de lepidopterología ·(unknown), Ashutosh Tamhane, Mohit Varshney, (unknown), Edgar T. Overton, (unknown), Ricardo Franco	10
14	Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010–2011 2016 ·AIDS Research and Human Retroviruses ·Pragna Patel, Timothy J. Bush, Erna M. Kojic, Edgar T. Overton, Keith Henry, Nur F. Önen, Frank S. Rhame, Lois Conley, John T. Brooks, Alicia M. Fry	8
15	Obesity Is Associated with Race/Sex Disparities in Diabetes and Hypertension Prevalence, But Not Cardiovascular Disease, Among HIV-Infected Adults 2015 ·AIDS Research and Human Retroviruses ·Amanda L. Willig, Andrew O. Westfall, Edgar T. Overton, Michael J. Mugavero, Greer Burkholder, David Kim, Eric Chamot, James L. Raper, Heidi M. Crane, Michael S. Saag, James H. Willig	30
16	Relationships Among HIV Infection, Metabolic Risk Factors, and Left Ventricular Structure and Function 2013 ·AIDS Research and Human Retroviruses ·W. Todd Cade, Edgar T. Overton, Kristin Mondy, Lisa de las Fuentes, Víctor G. Dávila‐Román, Alan D. Waggoner, Dominic N. Reeds, (unknown), Melissa J. Krauss, Linda R. Peterson, Kevin E. Yarasheski	3
17	The Detrimental Effect of Adversity on HIV Outcomes in the Era of Combined Anti-Retroviral Therapy 2012 ·World Journal of AIDS ·Corrado Cancedda, Katherine S. Eddens, (unknown), (unknown), Enbal Shacham, Edgar T. Overton	2
18	Transmitted Drug-Resistant HIV Type 1 Remains Prevalent and Impacts Virologic Outcomes Despite Genotype-Guided Antiretroviral Therapy 2011 ·AIDS Research and Human Retroviruses ·Toshibumi Taniguchi, Diana Nurutdinova, Jessica R. Grubb, Nur F. Önen, Enbal Shacham, (unknown), Edgar T. Overton	24
19	Routine Screening for Depression: Identifying a Challenge for Successful HIV Care 2009 ·AIDS Patient Care and STDs ·Enbal Shacham, Diana Nurutdinova, Veena A. Satyanarayana, (unknown), Edgar T. Overton	54
20	ACTG 5220: Hepatitis B Vaccine Responses in HIV-Infected Persons Using Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) 2008 ·46th Annual Meeting ·Edgar T. Overton	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact